Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic

Nav

General Info

Geography

France (FRA)

Germany (DEU)

Italy (ITA)

Republic of Korea (KOR)

United Kingdom (GBR)

United States of America (USA)

View all

Coverage type

Country

Time period covered

01/2015 - 12/2021

Data type

Scientific literature

Keywords

Alzheimer's disease and other dementias

Citation

Authors

Luo H, Lau WCY, Chai Y, Torre CO, Howard R, Liu KY, Lin X, Yin C, Fortin S, Kern DM, Lee DY, Park RW, Jang JW, Chui CSL, Li J, Reich C, Man KKC, Wong ICK

Journal

JAMA Psychiatry

Volume

Issue

Pages

211-219

Publication year

2023

Suggested citation

Luo H, Lau WCY, Chai Y, Torre CO, Howard R, Liu KY, Lin X, Yin C, Fortin S, Kern DM, Lee DY, Park RW, Jang JW, Chui CSL, Li J, Reich C, Man KKC, Wong ICK. Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic. JAMA Psychiatry. 2023; 80(3): 211-219.

DOI

10.1001/jamapsychiatry.2022.4448

PMID

36696128

GHDx Entry last modified on: Dec 19, 2023

Header sites

Search form

Main menu

Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic

Nav